Publications

  1. Rao AA, Gourde JA, Marri P, Galardy PJ, Khan SP, Rodriguez V. Congenital Amegakaryocytic Thrombocytopenia: A Case Report of Pediatric Twins Undergoing Matched Unrelated Bone Marrow Transplantation. J Pediatr Hematol Oncol. 2014 Aug 28.
    View PubMed
  2. Ruparel RK, Bogert JN, Moir CR, Ishitani MB, Khan SP, Rodriguez V, Zarroug AE. Synchronous splenectomy during cholecystectomy for hereditary spherocytosis: is it really necessary? J Pediatr Surg. 2014 Mar; 49(3):433-5.
    View PubMed
  3. Kumar R, Rodriguez V, Matsumoto JM, Khan SP, Weaver AL, McBane RD, Beebe TJ, Heit JA. Health-related quality of life in children and young adults with post-thrombotic syndrome: results from a cross-sectional study. Pediatr Blood Cancer. 2014 Mar; 61(3):546-51.
    View PubMed
  4. Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, Bleesing JJ, Filipovich AH, Jordan MB. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer. 2013 Jan; 60(1):101-9. Epub 2012 Apr 22.
    View PubMed
  5. Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012 Oct 18; 367(16):1487-96.
    View PubMed
  6. Khan S, Juckett MB, Komanduri KV, Krishnan A, Burns LJ, American Society of Blood and Marrow Transplantation Committee on Education. American Society of Blood and Marrow Transplantation Guidelines for Training in Hematopoietic Progenitor Cell Transplantation. Biol Blood Marrow Transplant. 2012 Sep; 18(9):1322-8. Epub 2012 Apr 19.
    View PubMed
  7. Nageswara Rao AA, Kumar R, Altaf S, Gourde JA, Rodriguez V, Khan SP. Pretransplant conditioning with Campath-1H (alemtuzumab) in pediatric matched unrelated hematopoietic stem cell transplants: an institutional experience. J Pediatr Hematol Oncol. 2012 Mar; 34(2):96-100.
    View PubMed
  8. Joshi A, Ham E, Shah N, Dong X, Khan S, Abraham R. Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency. Case Reports in Immunology. 2012; 2012.
  9. Kumar R, Galardy PJ, Dogan A, Rodriguez V, Khan SP. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma. Pediatr Blood Cancer. 2011 Aug; 57(2):317-20. Epub 2011 Apr 01.
    View PubMed
  10. Oliveira JL, Kumar R, Khan SP, Law ME, Erickson-Johnson M, Oliveira AM, Ketterling RP, Dogan A. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion. Pediatr Blood Cancer. 2011 Mar; 56(3):467-9. Epub 2010 Nov 11.
    View PubMed
  11. Kumar R, Khan SP, Joshi DD, Shaw GR, Ketterling RP, Feldman AL. Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A. Pediatr Blood Cancer. 2011 Feb; 56(2):307-10.
    View PubMed
  12. Kumar R, Rodriguez V, Khan SP, Laack N, Arndt CA. Post Radiation Dermatofibrosarcoma Protuberans in a Patient with Wilms tumor. Journal of pediatric hematology Oncology. 2011.
  13. Horn B, Soni S, Khan S, Petrovic A, Breslin N, Cowan M, Pelle-Day G, Cooperstein E, Baxter-Lowe LA. Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies. Bone Marrow Transplant. 2009 Mar; 43(6):469-76. Epub 2008 Oct 27.
    View PubMed
  14. Renaud DL, Khan S. Development of a multidisciplinary programme for the treatment of X-linked adrenoleukodystrophy. Paediatr. Child Health (CAN) 2009; 19(Suppl 2):S217-9.
    View PubMed
  15. Sabapathy C, Gourde JA, Khan SP, Rodriguez V. Tacrolimus with mini-methotrexate as prophylaxis for graft-versus-host disease in pediatric patients after allogeneic peripheral blood stem cell transplant or bone marrow transplant. J Pediatr Hematol Oncol. 2008 Dec; 30(12):945-9.
    View PubMed
  16. Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A, Manes B, Cole C, Walters MC, Ayas M, Ravindranath Y, Levine JE, Grupp SA. A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood. 2007 Dec 15; 110(13):4584-7 Epub 2007 Sep 7.
    View PubMed
  17. Rodriguez V, Anderson PM, Trotz BA, Arndt CA, Allen JA, Khan SP. Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut. Pediatr Blood Cancer. 2007 Aug; 49(2):212-5.
    View PubMed
  18. Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S, Carrum G, Khan SP, Heslop HE, Brenner MK, Bollard CM, Krance RA. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant. 2006 Dec; 12(12):1277-84.
    View PubMed
  19. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA, Territo MC, Collins RH, McSweeney PA, Copelan EA, Khan SP, Woolfrey A, Storer B. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood. 2006 Sep 1; 108(5):1485-91. Epub 2006 May 09.
    View PubMed
  20. Rodriguez V, Anderson PM, Litzow MR, Erlandson L, Trotz BA, Arndt CA, Khan SP, Wiseman GA. Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia. Leuk Lymphoma. 2006 Aug; 47(8):1583-92.
    View PubMed
  21. Imran H, Tleyjeh IM, Zirakzadeh A, Rodriguez V, Khan SP. Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. Bone Marrow Transplant. 2006 Apr; 37(7):677-86.
    View PubMed
  22. Rodriguez V, Khan SP. Late graft rejection following allogeneic bone marrow transplantation in aplastic anemia. Transplant Proc. 2002 Jun; 34(4):1307-9.
    View PubMed
  23. Rodriguez V, Kuehnle I, Heslop HE, Khan S, Krance RA. Guillain-Barre syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002 Mar; 29(6):515-7.
    View PubMed
  24. Mhawech P, Buffone GJ, Khan SP, Gresik MV. Cytochemical staining and flow cytometry methods Applied to the diagnosis of acute leukemia in the pediatric population: an assesment of relative usefulness. Journal of Pediatric Hematology/Oncology. 2001; 23(2):89-92.
  25. Deeg HJ, Amylon ID, Harris RE, Collins R, Beatty PG, Feig S, Ramsay N, Territo M, Khan SP, Pamphilon D, Leis JF, Burdach S, Anasetti C, Hackman R, Storer B, Mueller B. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Biol Blood Marrow Transplant. 2001; 7(4):208-15.
    View PubMed
  26. Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 2000; 11:1465-75.
    View PubMed
  27. Seber A, Khan SP, Kersey JH. Unexplained effusions: association with allogeneic BMT and acute or chronic GVHD. Bone marrow Transplantation. 1996; 17:207-11.
    View PubMed
  28. Davies SM, Khan SP, Wagner JE, Arthur DC, Auerbach AD, Ramsay NKC, Weisdorf DJ. Unrelated donor Bone marrow transplantation for fanconi anemia. Bone Marrow Transplantation. 1996; 17:43- 47.
    View PubMed
  29. Khan SP, Gilchrist GS, Arndt CA, Smithson WA, Chen MG, Schomberg PJ, Matsumoto JM, O'Fallon WM. Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. Mayo Clin Proc. 1994 Oct; 69(10):949-54.
    View PubMed
  30. Khan SP, Raza A, Yousuf N, Barcos M, Saikia T, Masterson M, Bennett J, Browman G, Goldberg J, Grunwald H, Larson R, Sandberg A, Vogler R, Priesler HD. Cell cycle and clinical characteristics of patients with myeloproliferative disorders whose biopsies are reactive with anti-factor VIII antibody : a leukemia inter-group study. Leukemia Research. 1991; 15:51-7.
    View PubMed
  31. Raza A, Khan SP, Mehdi I, Imren S, Yasin Z, Priesler HD. Cell cycle characteristics in Myeloid leukemias. Bone Marrow Transplantation Vol 4 suppl. 1989; 1:26-9.
  32. Raza A, Maheshwari Y, Mandava N, Yasin Z, Perveen S, Mayers G, Goldberg J, Gottlieb A, Grunwald H, Larson R, Miller K, Vogler R, Priesler HD. Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia. Sem Oncol 14 Suppl. 1987; 1:217-25.